Alice C. Fan
Key Documents
Contact Information
-
Clinical Offices
Oncology 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 725-9113
- Academic Offices
Personal Information Email Tel (650) 498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Lymphoma
- Medical Oncology
- Oncology (Cancer)
Administrative Appointments
- Co-Director, Stanford Nanopro1000 Instrument for Nano-scale protein detection (2008 - present)
Honors and Awards
- K23 Career Development Award, NIH/NCI (July 2010-June 2015)
- Special Fellow in Clinical Research, Leukemia and Lymphoma Society (July 2006-June 2009)
- Research Fellowship, Lymphoma Research Foundation (July 2004-June 2006)
- Dean's Fellowship, Stanford School of Medicine (April 2004- March 2005)
Professional Education
| Fellowship: | Stanford University Medical Center CA (2006) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2004) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2001) |
| Residency: | Brown University - School of Medicine RI (2001) |
| Internship: | Brown University - School of Medicine RI (1999) |
Graduate & Fellowship Program Affiliations
Community and International Work
Scientific Focus
Current Research Interests
Dr. Fan studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical studies. Based on preclinical findings, she has initiated a clinical trial studying atorvastatin for the treatment of patients with certain non-Hodgkin's lymphomas. In the laboratory, she also uses preclinical models of cancer to validate new nanotechnology strategies for tumor diagnosis and treatment.
Clinical Trials
Publications
- "Picolog," a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo. Oncotarget. 2012
- Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na. Leuk Res. 2012; (1): 98-103
- Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nat Med. 2009; (5): 566-71
- Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew Chem Int Ed Engl. 2009; (41): 7668-72
- A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice. Mol Cancer. 2008: 74
Help